Quantum Biopharma (QNTM) Accumulated Expenses (2024 - 2025)
Quantum Biopharma's (QNTM) quarterly Accumulated Expenses came in at $2.2 million in Q4 2025, up 98.71% year-on-year from $1.1 million in Q4 2024, and up 98.71% quarter-over-quarter from $1.1 million in Q4 2024.
Quantum Biopharma (QNTM) Accumulated Expenses (2024 - 2025) Analysis & Trends
Quantum Biopharma has disclosed Accumulated Expenses across 2 years of filings, most recently posting $2.2 million for Q4 2025.
- Accumulated Expenses for Q4 2025 came in at $2.2 million, up 98.71% year-over-year; the trailing twelve-month figure through Dec 2025 was $2.2 million (up 98.71% YoY), and the FY2025 annual result was $2.2 million, up 98.71% from the prior year.
- Accumulated Expenses came in at $2.2 million for Q4 2025 at Quantum Biopharma, up from $1.1 million in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $2.2 million in Q4 2025 to a low of $1.1 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.20 Mn |
| Dec 31, 2024 | 1.11 Mn |